Oceaneering International Inc
Change company Symbol lookup
Select an option...
OII Oceaneering International Inc
SINO Sino-Global Shipping America Ltd
MLM Martin Marietta Materials Inc
KO Coca-Cola Co
VICI VICI Properties Inc
PLT Plantronics Inc
THG Hanover Insurance Group Inc
USB U.S. Bancorp
BAC Bank of America Corp
TCNNF Trulieve Cannabis Corp

Energy : Energy Equipment & Services | Small Cap Value
Company profile

Oceaneering International, Inc. is an oilfield provider of engineered services and products, primarily to the offshore oil and gas industry, with a focus on deepwater applications. The Company's business segments are contained within two businesses: services and products provided to the oil and gas industry (Oilfield) and all other services and products (Advanced Technologies). Its four business segments within the Oilfield business are Remotely Operated Vehicles (ROVs), Subsea Products, Subsea Projects and Asset Integrity. The services and products it provides to the oil and gas industry include remotely operated vehicles, specialty subsea hardware, engineering and project management, subsea intervention services, including manned diving, survey and positioning services and asset integrity and nondestructive testing services. The Company serves the defense, aerospace and commercial theme park industries.


Last Trade
0.00 (0.00%)
B/A Size

Market Hours

Closing Price
Day's Change
0.23 (5.97%)
B/A Size
Day's High
Day's Low
(Heavy Day)

10-day average volume:

Shape Memory Medical Names Mary Dennehy as Vice President of Marketing

10:00 am ET September 25, 2020 (BusinessWire) Print

Shape Memory Medical Inc., developer of innovative therapies for cardiovascular and neurovascular markets, is pleased to announce and welcome Mary Dennehy as Vice President of Marketing. Mary will be responsible for driving the development and implementation of global marketing strategies and initiatives that support commercialization of its Shape Memory Polymer embolization products and therapies.

Mary brings over 20 years of medical device experience with organizations ranging from early stage start-ups to established global market leaders in the cardiovascular and orthopedic spine industries. Mary recently spent seven years at Endologix as Director of Global Marketing and later as Senior Director of Clinical Marketing and Health Economics with a focus on market development for the company's aortic endovascular therapies. Prior to these roles, Mary held senior-level product and corporate marketing positions in the U.S. and abroad at Kyphon (acquired by Medtronic) and Guidant Vascular Intervention (acquired by Abbott Vascular). Mary's marketing career also includes Syntactx, a premier global clinical research organization, and the world-renowned Arizona Heart Institute.

"As we continue to grow as an emerging global leader in therapies for peripheral embolization, hemorrhagic aneurysms and endovascular aortic aneurysms, Mary's broad leadership and experience will help make that vision a reality," said Ted Ruppel, President and Chief Executive Officer of Shape Memory Medical Inc. "Mary's proven background in market development, product launch, and communications will be crucial to our successful market growth. She also comes to us with a long history of collaborative relationships within the vascular community that will enable us to further advance our product development and clinical research initiatives."

"I am very excited to join the Shape Memory Medical team and to be a part of an organization with such an innovative and unique portfolio," said Mary of her new position. "I truly believe that our technology has great potential to address several unmet clinical needs, and I am particularly excited about our clinical work in the aortic aneurysm space. We announced last week the initiation of the prospective AAA-SHAPE study looking at the use of the IMPEDE-FX Embolization Plug to treat the abdominal aortic aneurysm sac during traditional EVAR procedures, and I look forward to working together with the physician community along this journey."

Mary earned a Bachelor of Science degree from Penn State University, a Master of Business Administration from the Franciscan University of Steubenville, and a Master of Health Administration from the University of Phoenix.

About Shape Memory Medical

Shape Memory Medical Inc., based in Santa Clara, California, is dedicated to developing innovative therapeutic solutions with its proprietary Shape Memory Polymers. Neurovascular embolization products include the TrelliX(R) Embolic Coil; CE marked for use in the EU. Peripheral embolization products include the IMPEDE(R) and IMPEDE-FX Embolization Plugs; both CE marked for use in the EU and cleared for use in the United States (US). In the United States, the IMPEDE-FX Embolization Plug is currently indicated for use with the IMPEDE Embolization Plug to obstruct or reduce the rate of blood flow in the peripheral vasculature. In countries recognizing CE marking, the IMPEDE-FX Embolization Plug is indicated for use to obstruct or reduce the rate of blood flow in the peripheral vasculature. For more information, visit www.shapemem.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200925005059/en/

SOURCE: Shape Memory Medical Inc.">

Mary Dennehy
comtex tracking

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.